Back to search

Switzerland· 61492008

Co-Candesartan Sandoz

A candesartan und diuretika product containing candesartanum cilexetilum, hydrochlorothiazidum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC C09DA06

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedCo-Candesartan SandozATCC09DA06REGISTER NO.61492008PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Candesartan und diuretika is registered in 12 of 19 countries.

Countries holding a registration under ATC C09DA06 (candesartan und diuretika), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 8 of them publish a price we can compare per daily dose

Candesartan und diuretika · ATC C09DA06

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
candesartanum cilexetilum, hydrochlorothiazidum
Manufacturer
—
Country
Switzerland (CH)
ATC code
C09DA06
ATC class
Candesartan und Diuretika
Swissmedic category
B
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680614920081
    98 Stk
    CHF 47.15

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

80 interactions on record for candesartan und diuretika.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Candesartan und diuretika · interactions on record

80 records

80 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Candesartan und diuretika in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All candesartan und diuretika products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Spain · Candesartán/Hidroclorotiazida Combix

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f1fbb6fb-35ec-45d9-81d5-ec14e4bf7a66
GET /v1/drugs/f1fbb6fb-35ec-45d9-81d5-ec14e4bf7a66?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "candesartanum cilexetilum 32 mg + hydrochlorothiazidum 25 mg",
  "valid_from": "2014-02-01",
  "limitations": null,
  "galenic_form": "Tabl 32/25 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2014-02-01",
  "self_retention_pct": 10
}

See everything about candesartan und diuretika.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.